| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/25/2003 | US20030180295 Angiocidin: a Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 09/25/2003 | US20030180275 Human serpin polypeptides |
| 09/25/2003 | US20030180267 Genetic engineering; controlling gene expression in situ |
| 09/25/2003 | US20030180261 Vaccines; cancer therapy; immobilization of virus; supplying tumor |
| 09/25/2003 | US20030180258 Viral vectors having tissue tropism for T-lymphocytes, B- and mast cells |
| 09/25/2003 | US20030180257 Alphavirus vectors for paramyxovirus vaccines |
| 09/25/2003 | US20030180256 Cytokine-like proteins |
| 09/25/2003 | US20030180225 Walnut and ryegrass allergens |
| 09/25/2003 | US20030180219 Calibrating efficiency of vaccines |
| 09/25/2003 | CA2819867A1 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
| 09/25/2003 | CA2799805A1 Optimizing glycan processing in plants |
| 09/25/2003 | CA2519169A1 Transgenic plants expressing enzymes involved in fatty acid biosynthesis |
| 09/25/2003 | CA2518626A1 An improved method for synthesising templated molecules |
| 09/25/2003 | CA2481399A1 Peptides and pharmaceutical compositions comprising said peptides for treating cancer |
| 09/25/2003 | CA2479733A1 Saccharomyces cerevisiae mutant |
| 09/25/2003 | CA2479409A1 Double-stranded ribonucleic acid constructs and methods for reducing expression of genes in plants |
| 09/25/2003 | CA2479247A1 Synthesis of synthons for the manufacture of bioactive compounds |
| 09/25/2003 | CA2479246A1 Method for overexpression of zwitterionic polysaccharides |
| 09/25/2003 | CA2479154A1 Novel genes |
| 09/25/2003 | CA2479153A1 Hybrid and single chain meganucleases and use thereof |
| 09/25/2003 | CA2479152A1 Methods of inducing differentiation of stem cells into a specific cell lineage |
| 09/25/2003 | CA2479118A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 09/25/2003 | CA2479042A1 Cartilage regeneration using chondrocyte and tgf-.beta. |
| 09/25/2003 | CA2478986A1 Method of identifying genes controlling differentiation |
| 09/25/2003 | CA2478973A1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 09/25/2003 | CA2478875A1 Methods for generating double stranded dna comprising a 3' single stranded portion and uses of these complexes for recombination |
| 09/25/2003 | CA2478850A1 Gene expression profiling in biopsied tumor tissues |
| 09/25/2003 | CA2478803A1 Methods of modulating cd200 receptors |
| 09/25/2003 | CA2478790A1 Polypeptides binding to human syntaxin 1a |
| 09/25/2003 | CA2478692A1 Engineered baculoviruses and their use |
| 09/25/2003 | CA2478651A1 Method of inducing an enhanced immune response against hiv |
| 09/25/2003 | CA2478334A1 Positioning system for moving a selected station of a holding plate to a predetermined location for interaction with a probe |
| 09/25/2003 | CA2478294A1 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
| 09/25/2003 | CA2477911A1 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits |
| 09/25/2003 | CA2477670A1 Improved nucleic acid amplification |
| 09/25/2003 | CA2477452A1 Cloning of cytochrome p450 genes from nicotiana |
| 09/25/2003 | CA2477194A1 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
| 09/25/2003 | CA2474905A1 Alcohol dehydrogenases with high solvent and temperature stability |
| 09/25/2003 | CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/25/2003 | CA2455607A1 Multiple controls for molecular genetic analyses |
| 09/25/2003 | CA2454368A1 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins |
| 09/24/2003 | EP1347297A1 Method of reusing dna-immobilization substrate |
| 09/24/2003 | EP1347064A2 Base sequence characteristic of small round-structured viruses |
| 09/24/2003 | EP1347062A1 Method of detecting abnormal gene |
| 09/24/2003 | EP1347061A1 Method of quantifying hiv-1 rna-dna hybrid and diagnosis kit |
| 09/24/2003 | EP1347057A1 Method for L-threonine production |
| 09/24/2003 | EP1347056A1 Gene encoding acetolactic acid synthase gene |
| 09/24/2003 | EP1347055A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 09/24/2003 | EP1347054A1 TAP-70, a novel marker for epithelial tumors |
| 09/24/2003 | EP1347053A1 Process for producing rfrp |
| 09/24/2003 | EP1347052A1 Guanosine triphosphate (gtp) binding protein-coupled receptor protein, bg37 |
| 09/24/2003 | EP1347051A1 Method of examining allergic disease |
| 09/24/2003 | EP1347049A1 Novel potassium channel |
| 09/24/2003 | EP1347047A2 Mice lacking inward-rectifying potassium channel Kir6.1 |
| 09/24/2003 | EP1347046A1 Full-length cDNA sequences |
| 09/24/2003 | EP1347045A1 Enzyme with proteolytic activity |
| 09/24/2003 | EP1347042A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it |
| 09/24/2003 | EP1346999A2 Human secreted protein |
| 09/24/2003 | EP1346998A1 Equine arteritis virus vaccine |
| 09/24/2003 | EP1346771A1 Microplate manufactured from a thermally conductive material and methods for making and using such microplates |
| 09/24/2003 | EP1346731A1 Conjugates for treating inflammatory disorders and associated tissue damage |
| 09/24/2003 | EP1346730A1 Pretargeting methods and novel pretargeting conjugates |
| 09/24/2003 | EP1346226A1 Screening method based on siah-numb interaction |
| 09/24/2003 | EP1346218A1 Tripeptide of fc gama riia |
| 09/24/2003 | EP1346065A2 Antisense modulation of src-2 expression |
| 09/24/2003 | EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 09/24/2003 | EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol |
| 09/24/2003 | EP1346058A2 Adenoviral systems and the uses thereof |
| 09/24/2003 | EP1346057A2 Method for producing heterologous proteins in a homothallic fungus of the sordariaceae family |
| 09/24/2003 | EP1346056A1 Methods for the production of multimeric proteins, and related compositions |
| 09/24/2003 | EP1346055A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 09/24/2003 | EP1346054A2 Nucleic acids coding for vacuolar invertases, vegetal cells and plants containing said nucleic acids and the use thereof |
| 09/24/2003 | EP1346053A2 Polynucleotides encoding human phosphatases |
| 09/24/2003 | EP1346052A2 Histone deacetylase-related gene and protein |
| 09/24/2003 | EP1346051A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/24/2003 | EP1346050A2 Regulators of fungal gene expression |
| 09/24/2003 | EP1346049A2 EFFICIENT EXPRESSION OF i PLASMODIUM /i APICAL MEMBRANE ANTIGEN 1 IN YEAST CELLS |
| 09/24/2003 | EP1346048A1 Mycoplasma spp. a39 |
| 09/24/2003 | EP1346047A2 Yeasts transformed by genes enhancing their cold stress tolerance |
| 09/24/2003 | EP1346046A2 Elongase promoters |
| 09/24/2003 | EP1346045A1 Human protooncogene and protein encoded therein |
| 09/24/2003 | EP1346044A2 Bax-responsive genes for drug target identification in yeast and fungi |
| 09/24/2003 | EP1346043A2 Compositions and methods relating to lung specific genes and proteins |
| 09/24/2003 | EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 09/24/2003 | EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/24/2003 | EP1346040A2 Novel nucleic acids and polypeptides |
| 09/24/2003 | EP1346039A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 09/24/2003 | EP1346038A2 Methods and compositions for inhibiting neoplastic cell growth |
| 09/24/2003 | EP1346037A2 Compositions and methods for extracting a nucleic acid |
| 09/24/2003 | EP1346036A2 Helper virus-free herpes virus amplicon particles and uses thereof |
| 09/24/2003 | EP1346035A2 Plant transcription factors |
| 09/24/2003 | EP1346034A2 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE |
| 09/24/2003 | EP1346033A2 Novel serine protease genes related to dppiv |
| 09/24/2003 | EP1346032A2 Method for the production of carbohydrates |
| 09/24/2003 | EP1346031A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 09/24/2003 | EP1346030A1 Low-lipoxygenase 1 barley |
| 09/24/2003 | EP1346029A2 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 09/24/2003 | EP1346028A2 Cell culture apparatus and methods of use |
| 09/24/2003 | EP1345969A2 Anti-cd28 antibody |
| 09/24/2003 | EP1345967A2 Phage display libraries of human v h fragments |